Fifth Third Bancorp
PTLA

Fifth Third Bancorp’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Fifth Third Bancorp’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,000
Closed -$7K – 2313
2020
Q1 		$7K Buy
+1,000
New +$12.5K ﹤0.01% 1830
2019
Q2 		– Sell
-325
Closed -$11K – 2410
2019
Q1 		$11K Buy
325
+165
+103% +$4.76K ﹤0.01% 1768
2018
Q4 		$3K Buy
+160
New +$3.29K ﹤0.01% 2087
2015
Q4 		– Sell
-28
Closed -$1K – 2954
2015
Q3 		$1K Buy
+28
New +$1.35K ﹤0.01% 2825

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Fifth Third Bancorp's PTLA Position: Q2 2020 in Review

Fifth Third Bancorp sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 1,000 shares — an estimated $7K sold.

Fifth Third Bancorp first reported a position in PTLA in Q3 2015 and held it in 4 quarters. The position peaked at $11K in Q1 2019. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • Fifth Third Bancorp reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Fifth Third Bancorp sold 1,000 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $7K.
  • Fifth Third Bancorp first reported a position in Portola Pharmaceuticals, Inc. in Q3 2015 and held it in 4 quarters.
  • Fifth Third Bancorp's Portola Pharmaceuticals, Inc. position peaked at $11K in Q1 2019.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Fifth Third Bancorp's 13F filing for Q2 2020, filed 5 Aug 2020.